Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Stanley Erck
Age : 72
Public asset : 2,622,703 USD
Country of residence : Unknown
Linked companies : Novavax, Inc. - MaxCyte, Inc.

Biography of Stanley Erck 
Mr. Stanley C. Erck is a President, Chief Executive Officer & Director at Novavax, Inc. and an Independent Non-Executive Director at MaxCyte, Inc. He is on the Board of Directors at Novavax, Inc., MdBio Foundation and MaxCyte, Inc. Mr. Erck was previously employed as an Independent Director by BioCryst Pharmaceuticals, Inc., a President, Chief Executive Officer & Director by Iomai Corp., a Head-Global Regulatory Affairs Vaccines by Baxter International, Inc., a Vice President-Corporate Development by Integrated Genetics, Inc., and a President, Chief Executive Officer & Director by Procept, Inc. He received his undergraduate degree from the University of Illinois and an MBA from The University of Chicago Booth School of Business.


Current positions of Stanley Erck 
Holdings of Stanley Erck 
Stanley Erck : Personal Network 
Most Read News 
05/20XAVIER NIEL : UWR shares spike as billionaire Xavier Niel discloses 27% stake
RE
05/14ELON MUSK : Elon Musk says Twitter legal team told him he violated an NDA
RE
05/24ELON MUSK : In a faceoff with Elon Musk, the SEC blinked
RE
05/19ELON MUSK : Musk says 'Tesla is on my mind 24/7' amid concerns about Twitter distraction
RE
05/17ELON MUSK : Prominent hedge funds invested in Twitter before Musk unveiled plans
RE
05/25ELON MUSK : Twitter investors vote against re-electing Elon Musk ally to board
RE
05/27ELON MUSK : Musk sued by Twitter investors for stock 'manipulation' during takeover bid
RE
05/23HOCK TAN : Chipmaker Broadcom in talks to acquire VMware for $60 billion -sources
RE
05/17JPMorgan shareholders vote disapproval of CEO Dimon's special payout
RE
05/20LUCA DE MEO : Renault boss Luca de Meo could return to Japan in June - source
RE
More news


© 2022 People and Ownership :   
Stanley Erck : Connections 


Latest news about Stanley Erck 
02/28Novavax Eyes COVID-19 Jab's Full Approval in H2, Forecasts Up to $5 Billion Revenue
MT
02/28Novavax expects to apply for full approval of COVID vaccine in H2
RE
02/23Novavax starts shipping COVID vaccine to EU states
RE
01/31Novavax, after delays, files for U.S. authorization of COVID-19 vaccine
RE
01/10Novavax Initiates COVID-19 Shipments To Europe
MT
2021NOVAVAX CEO STANLEY ERCK SAYS IN Q1 OF 2022 CO WILL BE ABLE TO PRODUCE 2 BILLION COVID-19 VACCINE DOSES ON GLOBAL BASIS - CNBC Interview
RE
More news